TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Circulating Tumor Cells CTCs Cancer Stem Cells CSCs Market
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market, Global Outlook and Forecast 2023-2029

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market, Global Outlook and Forecast 2023-2029

  • Category:Life Sciences
  • Published on : 28 March 2023
  • Pages :112
  • Formats:
  • Report Code:SMR-7618223
OfferClick for best price

Best Price: $2600

Circulating Tumor Cells CTCs Cancer Stem Cells CSCs Market Size, Share 2023


Market size in 2022 US$ 14800 million
 Forecast Market size by 2029 US$ 54520 million
Growth Rate CAGR of 20.5% Number of Pages 112 Pages

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.

Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.

This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs). This report contains market size and forecasts of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in global, including the following market information:

  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global top five companies in 2022 (%)

The global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market was valued at US$ 14800 million in 2022 and is projected to reach US$ 54520 million by 2029, at a CAGR of 20.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market include Janssen, Qiagen, Advanced Cell Diagnostics, etc. North America and Europe are main markets, they occupy about 65% of the global market. CellSearch is the main type, with a share about 70%. Breast Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment are main applications, which hold a share about 60%.

We surveyed the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segment Percentages, by Type, 2022 (%)

  • CellSearch

  • Others

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segment Percentages, by Application, 2022 (%)

  • Breast Cancer Diagnosis and Treatment

  • Prostate Cancer Diagnosis and Treatment

  • Colorectal Cancer Diagnosis and Treatment

  • Lung Cancer Diagnosis and Treatment

  • Other Cancers Diagnosis and Treatment

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segment Percentages, By Region and Country, 2022 (%)

  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) revenues in global market, 2018-2023 (estimated), ($ millions)

  • Key companies Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) revenues share in global market, 2022 (%)

  • Further, the report presents profiles of competitors in the market, key players include:

  • Janssen

  • Qiagen

  • Advanced Cell Diagnostics

  • ApoCell

  • Biofluidica

  • Clearbridge Biomedics

  • CytoTrack

  • Celsee

  • Fluxion

  • Gilupi

  • Cynvenio

  • On-chip

  • YZY Bio

  • BioView

  • Fluidigm

  • Ikonisys

  • AdnaGen

  • IVDiagnostics

  • Miltenyi Biotec

  • ScreenCell

  • Silicon Biosystems

  • Outline of Major Chapters:

  • Chapter 1: Introduces the definition of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), market overview.

  • Chapter 2: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size in revenue.

  • Chapter 3: Detailed analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

  • Chapter 6: Sales of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

  • Chapter 8: The main points and conclusions of the report.

Report Attributes Report Details
Report Title Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market, Global Outlook and Forecast 2023-2029
Market size in 2022 US$ 14800 million
Forecast Market size by 2029 US$ 54520 million
Growth Rate CAGR of 20.5%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 112 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Overall Market Size
2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size: 2022 VS 2029
2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players in Global Market
3.2 Top Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies Ranked by Revenue
3.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Companies
3.4 Top 3 and Top 5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players in Global Market
3.6.1 List of Global Tier 1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Markets, 2022 & 2029
4.1.2 CellSearch
4.1.3 Others
4.2 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue & Forecasts
4.2.1 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2023
4.2.2 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2024-2029
4.2.3 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2022 & 2029
5.1.2 Breast Cancer Diagnosis and Treatment
5.1.3 Prostate Cancer Diagnosis and Treatment
5.1.4 Colorectal Cancer Diagnosis and Treatment
5.1.5 Lung Cancer Diagnosis and Treatment
5.1.6 Other Cancers Diagnosis and Treatment
5.2 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue & Forecasts
5.2.1 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2023
5.2.2 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2024-2029
5.2.3 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2022 & 2029
6.2 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue & Forecasts
6.2.1 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2023
6.2.2 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2024-2029
6.2.3 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.3.2 US Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.3.3 Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.3.4 Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.4.2 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.3 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.4 U.K. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.5 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.6 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.7 Nordic Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.8 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.5.2 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.3 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.4 South Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.5 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.6 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.6.2 Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.6.3 Argentina Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.7.2 Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7.3 Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7.4 Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7.5 UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
7 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies Profiles
7.1 Janssen
7.1.1 Janssen Company Summary
7.1.2 Janssen Business Overview
7.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.1.4 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.1.5 Janssen Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.2.4 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Advanced Cell Diagnostics
7.3.1 Advanced Cell Diagnostics Company Summary
7.3.2 Advanced Cell Diagnostics Business Overview
7.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.3.4 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.3.5 Advanced Cell Diagnostics Key News & Latest Developments
7.4 ApoCell
7.4.1 ApoCell Company Summary
7.4.2 ApoCell Business Overview
7.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.4.4 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.4.5 ApoCell Key News & Latest Developments
7.5 Biofluidica
7.5.1 Biofluidica Company Summary
7.5.2 Biofluidica Business Overview
7.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.5.4 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.5.5 Biofluidica Key News & Latest Developments
7.6 Clearbridge Biomedics
7.6.1 Clearbridge Biomedics Company Summary
7.6.2 Clearbridge Biomedics Business Overview
7.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.6.4 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.6.5 Clearbridge Biomedics Key News & Latest Developments
7.7 CytoTrack
7.7.1 CytoTrack Company Summary
7.7.2 CytoTrack Business Overview
7.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.7.4 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.7.5 CytoTrack Key News & Latest Developments
7.8 Celsee
7.8.1 Celsee Company Summary
7.8.2 Celsee Business Overview
7.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.8.4 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.8.5 Celsee Key News & Latest Developments
7.9 Fluxion
7.9.1 Fluxion Company Summary
7.9.2 Fluxion Business Overview
7.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.9.4 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.9.5 Fluxion Key News & Latest Developments
7.10 Gilupi
7.10.1 Gilupi Company Summary
7.10.2 Gilupi Business Overview
7.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.10.4 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.10.5 Gilupi Key News & Latest Developments
7.11 Cynvenio
7.11.1 Cynvenio Company Summary
7.11.2 Cynvenio Business Overview
7.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.11.4 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.11.5 Cynvenio Key News & Latest Developments
7.12 On-chip
7.12.1 On-chip Company Summary
7.12.2 On-chip Business Overview
7.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.12.4 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.12.5 On-chip Key News & Latest Developments
7.13 YZY Bio
7.13.1 YZY Bio Company Summary
7.13.2 YZY Bio Business Overview
7.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.13.4 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.13.5 YZY Bio Key News & Latest Developments
7.14 BioView
7.14.1 BioView Company Summary
7.14.2 BioView Business Overview
7.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.14.4 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.14.5 BioView Key News & Latest Developments
7.15 Fluidigm
7.15.1 Fluidigm Company Summary
7.15.2 Fluidigm Business Overview
7.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.15.4 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.15.5 Fluidigm Key News & Latest Developments
7.16 Ikonisys
7.16.1 Ikonisys Company Summary
7.16.2 Ikonisys Business Overview
7.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.16.4 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.16.5 Ikonisys Key News & Latest Developments
7.17 AdnaGen
7.17.1 AdnaGen Company Summary
7.17.2 AdnaGen Business Overview
7.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.17.4 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.17.5 AdnaGen Key News & Latest Developments
7.18 IVDiagnostics
7.18.1 IVDiagnostics Company Summary
7.18.2 IVDiagnostics Business Overview
7.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.18.4 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.18.5 IVDiagnostics Key News & Latest Developments
7.19 Miltenyi Biotec
7.19.1 Miltenyi Biotec Company Summary
7.19.2 Miltenyi Biotec Business Overview
7.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.19.4 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.19.5 Miltenyi Biotec Key News & Latest Developments
7.20 ScreenCell
7.20.1 ScreenCell Company Summary
7.20.2 ScreenCell Business Overview
7.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.20.4 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.20.5 ScreenCell Key News & Latest Developments
7.21 Silicon Biosystems
7.21.1 Silicon Biosystems Company Summary
7.21.2 Silicon Biosystems Business Overview
7.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.21.4 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.21.5 Silicon Biosystems Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Opportunities & Trends in Global Market
Table 2. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Drivers in Global Market
Table 3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Restraints in Global Market
Table 4. Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Global Market
Table 5. Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type
Table 9. List of Global Tier 1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2024-2029
Table 30. Janssen Company Summary
Table 31. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 32. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 33. Janssen Key News & Latest Developments
Table 34. Qiagen Company Summary
Table 35. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 36. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 37. Qiagen Key News & Latest Developments
Table 38. Advanced Cell Diagnostics Company Summary
Table 39. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 40. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 41. Advanced Cell Diagnostics Key News & Latest Developments
Table 42. ApoCell Company Summary
Table 43. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 44. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 45. ApoCell Key News & Latest Developments
Table 46. Biofluidica Company Summary
Table 47. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 48. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 49. Biofluidica Key News & Latest Developments
Table 50. Clearbridge Biomedics Company Summary
Table 51. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 52. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 53. Clearbridge Biomedics Key News & Latest Developments
Table 54. CytoTrack Company Summary
Table 55. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 56. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 57. CytoTrack Key News & Latest Developments
Table 58. Celsee Company Summary
Table 59. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 60. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 61. Celsee Key News & Latest Developments
Table 62. Fluxion Company Summary
Table 63. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 64. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 65. Fluxion Key News & Latest Developments
Table 66. Gilupi Company Summary
Table 67. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 68. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 69. Gilupi Key News & Latest Developments
Table 70. Cynvenio Company Summary
Table 71. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 72. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 73. Cynvenio Key News & Latest Developments
Table 74. On-chip Company Summary
Table 75. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 76. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 77. On-chip Key News & Latest Developments
Table 78. YZY Bio Company Summary
Table 79. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 80. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 81. YZY Bio Key News & Latest Developments
Table 82. BioView Company Summary
Table 83. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 84. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 85. BioView Key News & Latest Developments
Table 86. Fluidigm Company Summary
Table 87. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 88. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 89. Fluidigm Key News & Latest Developments
Table 90. Ikonisys Company Summary
Table 91. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 92. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 93. Ikonisys Key News & Latest Developments
Table 94. AdnaGen Company Summary
Table 95. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 96. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 97. AdnaGen Key News & Latest Developments
Table 98. IVDiagnostics Company Summary
Table 99. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 100. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 101. IVDiagnostics Key News & Latest Developments
Table 102. Miltenyi Biotec Company Summary
Table 103. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 104. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 105. Miltenyi Biotec Key News & Latest Developments
Table 106. ScreenCell Company Summary
Table 107. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 108. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 109. ScreenCell Key News & Latest Developments
Table 110. Silicon Biosystems Company Summary
Table 111. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Offerings
Table 112. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$, Mn) & (2018-2023)
Table 113. Silicon Biosystems Key News & Latest Developments
List of Figures
Figure 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Type in 2022
Figure 2. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Application in 2022
Figure 3. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in 2022
Figure 8. By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 16. US Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 20. Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 21. France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 28. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 32. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 34. Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
Figure 37. Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, (US$, Mn), 2018-2029
Figure 41. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Download
Free Sample
Request
Customization
Check
Discount

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount